Significantly, administration of CCPA to kidneys receiving L-p-bromotetramisole reversed a lot of the suppression of NE responses induced simply by L-p-bromotetramisole. Open in another window Figure 5 Reversal and prevention of L-p-bromtetramisole-induced inhibition of renovascular replies to norepinephrineBar graphs depict the power from the highly selective A1-receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA; 100 nmol/L) to invert (-panel […]